These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 34143331

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Downregulation of SOX21-AS1 Alleviated Cisplatin Resistance in Cervical Cancer Through Epithelial-Mesenchymal Transition Inhibition.
    Tian J, Li Z, Jiang Y, Gu W, Kong E, Hao Q, Kong B, Sun L.
    Rejuvenation Res; 2022 Oct; 25(5):243-252. PubMed ID: 36039935
    [Abstract] [Full Text] [Related]

  • 3. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
    Wei L, Qin XP, Zhao XX, Wang W.
    Zhonghua Fu Chan Ke Za Zhi; 2017 Aug 25; 52(8):551-557. PubMed ID: 28851173
    [Abstract] [Full Text] [Related]

  • 4. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
    Zheng Y, Xie L, Xu S, Yan W, Zhang H, Meng Y, Liu J, Wei X.
    Mol Cell Biochem; 2021 Nov 25; 476(11):4031-4044. PubMed ID: 34244973
    [Abstract] [Full Text] [Related]

  • 5. Period circadian regulator 2 suppresses drug resistance to cisplatin by PI3K/AKT pathway and improves chronochemotherapeutic efficacy in cervical cancer.
    Wang Z, Li F, He S, Zhao L, Wang F.
    Gene; 2022 Jan 30; 809():146003. PubMed ID: 34648915
    [Abstract] [Full Text] [Related]

  • 6. Down-regulation of Frizzled-7 expression inhibits migration, invasion, and epithelial-mesenchymal transition of cervical cancer cell lines.
    Deng B, Zhang S, Miao Y, Zhang Y, Wen F, Guo K.
    Med Oncol; 2015 Apr 30; 32(4):102. PubMed ID: 25740178
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Human papillomavirus oncoproteins differentially modulate epithelial-mesenchymal transition in 5-FU-resistant cervical cancer cells.
    Vishnoi K, Mahata S, Tyagi A, Pandey A, Verma G, Jadli M, Singh T, Singh SM, Bharti AC.
    Tumour Biol; 2016 Oct 30; 37(10):13137-13154. PubMed ID: 27449048
    [Abstract] [Full Text] [Related]

  • 9. Role of microRNA-4739 in enhancing cisplatin chemosensitivity by negative regulation of RHBDD2 in human cervical cancer cells.
    Li Y, Zhou Z, Qu J, Gong P, Wei Y, Sun Y.
    Cell Mol Biol Lett; 2024 Jan 25; 29(1):20. PubMed ID: 38267862
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Interference with endogenous EZH2 reverses the chemotherapy drug resistance in cervical cancer cells partly by up-regulating Dicer expression.
    Cai L, Wang Z, Liu D.
    Tumour Biol; 2016 May 25; 37(5):6359-69. PubMed ID: 26631032
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Effect of RBP2 gene silencing on proliferation, migration and invasion of ovarian epithelial cancer SKOV3/DDP cells and its mechanism].
    Feng TF, Yao DM, Zheng R, Jiang DS, Zhang LL, Xing Q, Li L.
    Zhonghua Zhong Liu Za Zhi; 2022 Feb 23; 44(2):139-146. PubMed ID: 35184457
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Design and Synthesis of Novel α-Methylchalcone Derivatives, Anti-Cervical Cancer Activity, and Reversal of Drug Resistance in HeLa/DDP Cells.
    Yang Z, Liu Z, Ablise M, Maimaiti A, Aihaiti A, Alimujiang Y.
    Molecules; 2023 Nov 21; 28(23):. PubMed ID: 38067428
    [Abstract] [Full Text] [Related]

  • 20. SPP1 inhibition improves the cisplatin chemo-sensitivity of cervical cancer cell lines.
    Chen X, Xiong D, Ye L, Yang H, Mei S, Wu J, Chen S, Mi R.
    Cancer Chemother Pharmacol; 2019 Apr 21; 83(4):603-613. PubMed ID: 30627777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.